PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 46 filers reported holding PASSAGE BIO INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,401,000 | -78.7% | 140,699 | -71.6% | 0.05% | -78.7% |
| Q2 2021 | $6,566,000 | -24.8% | 495,931 | -0.7% | 0.24% | -24.1% |
| Q1 2021 | $8,732,000 | +0.2% | 499,541 | +46.6% | 0.32% | +9.0% |
| Q4 2020 | $8,712,000 | +94.5% | 340,698 | -0.3% | 0.29% | +57.1% |
| Q3 2020 | $4,479,000 | -53.5% | 341,627 | -3.2% | 0.18% | -56.2% |
| Q2 2020 | $9,640,000 | +72.6% | 352,743 | -0.5% | 0.42% | +30.0% |
| Q1 2020 | $5,585,000 | – | 354,601 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,648,629 | 2.12% |
| Versant Venture Management, LLC | 4,959,769 | $3,263,528 | 1.74% |
| BML Capital Management, LLC | 2,058,767 | $1,354,669 | 1.24% |
| Acuitas Investments, LLC | 418,161 | $275,150 | 0.16% |
| Orbimed Advisors | 10,124,576 | $6,661,971 | 0.14% |
| Lynx1 Capital Management LP | 190,124 | $125,102 | 0.08% |
| Frazier Life Sciences Management, L.P. | 1,758,219 | $1,156,908 | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $263,200 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $56,621 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 506,600 | $333,343 | 0.01% |